Hasan Karadağ

Hasan Karadağ

Auto-generated profile, based on publicly available information

Hasan Karadağ

Department of Psychiatry, Ankara Etlik City Hospital, Ankara, Türkiye

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2019 in Journal of Clinical Psychopharmacology
Verified
Journal Article
Open access
HDHalise Devrimci-Ozguven
Halise Devrimci-Ozguven
MAMurad Atmaca
Murad Atmaca
ZBZeynep Baran
Zeynep Baran
CCCengiz Cengisiz
Cengiz Cengisiz
CÇCem Çinar
Cem Çinar
MYMesut Yildiz
Mesut Yildiz
Purpose: The aim of the study was to assess efficacy and safety of paliperidone palmitate (PP) in schizophrenic patients using real-life data. Methods: This national, multicenter, retrospective, and mirror-image study was performed reviewing the medical records of patients in 18 centers. Adult schizophrenic patients receiving PP treatment (n = 205) were enrolled. Patients' data covering the last 12 months before the initial PP injection and the period until the end of study with at least 12 months after the initial PP injection were evaluated. Patients' characteristics, scale scores, and adverse events were recorded. Results: Nonadherence to prior medication was the most frequent reason for switching to PP treatment. Comparing with the period before PP treatment, the rate of patients visiting the hospital for relapse (79.5% vs 28.9%, P < 0.001) and the median number of hospitalizations (2 vs 0, P < 0.001) were lower during PP treatment. During PP treatment, the Positive and Negative Syndrome Scale score decreased by 20% or more (response to treatment) in 75.7% of the patients. The frequency of adverse events did not differ between the period before and during PP treatment. Improvement in functionality was higher in those with disease duration of 5 years or less. Conclusions: Paliperidone palmitate is effective and safe in treatment of schizophrenic patients and in switching to PP treatment in patients with schizophrenia, which reduced the percentage of patients admitted to the hospital for relapse and the median number hospitalization, and has positive effects on functionality.

1 September 2022 in Turkish Journal of Surgery
Verified
Journal Article
Open access
PDF file
AGAyşe Gökçen Gündoğmuş
Ayşe Gökçen Gündoğmuş
YKYasemin Koçyiğit
Yasemin Koçyiğit
HKHasan Karadağ
Hasan Karadağ
Objective: Considering the effects of self-esteem, eating attitudes and body satisfaction on obesity and bariatric surgery outcomes, psychiatric evaluation is important for the identification and treatment of psychopathology, improvement of self-esteem, eating attitudes and body satisfaction. In this study, it was aimed to determine the relation between eating behaviors, body dissatisfaction, self-esteem and psychological symptoms in patients seeking bariatric surgery. Our second aim was to determine whether depressive symptoms and anxiety had a mediating role in the relationship between body satisfaction and self-esteem and eating attitudes. Material and Methods: The study included 200 patients. Patients’ data were retrospectively evaluated. Psychometric evaluation performed during the preoperative period included psychiatric examination and administration of the Beck Depression Inventory, Beck Anxiety Inventory, Rosenberg SelfEsteem Scale, Body-Cathexis Scale, and Dutch Eating Behaviors Questionnaire. Results: There was a positive correlation between self-esteem and body satisfaction and a negative correlation between self-esteem and emotional eating (r= 0.160, p= 0.024; r= -0.261, p< 0.001 respectively). Body satisfaction had an effect on emotional eating mediated by depression and an effect on external and restrictive eating mediated by anxiety. Furthermore, anxiety mediated the relations between self-esteem and external and restrictive eating behaviors. Conclusion: Our finding indicating that depression and anxiety have mediator effects on the relation between self-esteem, body dissatisfaction, and eating attitudes is significant since screening for these entities and their treatment is relatively more practical in clinical settings.

10 February 2026 in Journal of Psychiatric Research
Verified
Journal Article
Closed access
ŞKŞeyma Işık Karakulak
Şeyma Işık Karakulak
SBSüheyla Doğan Bulut
Süheyla Doğan Bulut
HKHasan Karadağ
Hasan Karadağ
ZKZeynep Adıyaman Koçer
Zeynep Adıyaman Koçer

27 June 2026 in Journal of Eating Disorders
Verified
Journal Article
Open access
HÜHasan Ünver
Hasan Ünver
STSafiye Zeynep Tatlı
Safiye Zeynep Tatlı
İGİbrahim Gündoğmuş
İbrahim Gündoğmuş
HKHasan Karadağ
Hasan Karadağ
KÖKadir Özdel
Kadir Özdel
GEGamze Erzin
Gamze Erzin
This study aimed to evaluate the validity and reliability of the Turkish version of the Barcelona Bipolar Eating Disorder Scale (BEDS), which can facilitate screening for comorbid eating disorders (EDs) in bipolar disorder (BD) patients. A total of 100 BD patients and 129 healthy controls (HCs) were included in the study conducted at Ankara Etlik City Hospital Psychiatry Clinic. These patients were diagnosed according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), and the Structured Clinical Interview for DSM-5 (SCID-5). Sociodemographic forms, the Turkish version of the BEDS, the Young Mania Rating Scale (YMRS), the Hamilton Depression Rating Scale (HAM-D), the Brief Psychiatric Rating Scale (BPRS), the Bulimic Investigatory Test, Edinburgh (BITE), and the Dutch Eating Behavior Questionnaire (DEBQ) were used to assess validity and reliability. No statistically significant differences were found between the patient and control groups regarding the BITE and BEDS total scores. For the DEBQ, no significant group differences were observed in the total, restrained eating, or external eating scores, whereas the healthy control group had higher emotional eating scores. The correlation coefficient between each item and the total score ranged from 0.313 to 0.644. Cronbach's alpha for the scale was 0.821. The removal of any items from the original scale did not lead to an improvement in Cronbach's alpha. The BEDS score was found to be significantly correlated with the BITE score, DEBQ total score, emotional eating score, and external eating score (p < 0.001). There was no correlation between the BEDS score and the DEBQ restrictive eating subscale, YMRS, BPRS, or HAM-D scale scores. The Turkish version of the BEDS is a valid and reliable scale that can be used as an assessment tool in the evaluation of eating disorders in the Turkish BD population.